HMG-CoA Reductase Inhibitor [EPC]

373656 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN ROSUVASTATIN ATORVASTATIN CALCIUM EZETIMIBE AND SIMVASTATIN PITAVASTATIN MAGNESIUM

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 26565
1 NAUSEA 23887
2 DYSPNOEA 23021
3 DRUG INEFFECTIVE 22726
4 DIARRHOEA 22639
5 DIZZINESS 19465
6 PAIN 17444
7 HEADACHE 17400
8 ASTHENIA 16492
9 OFF LABEL USE 16038
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOPATHY 2090 0.2417
1 NEPHROGENIC ANAEMIA 1041 0.2245
2 RHABDOMYOLYSIS 8963 0.2147
3 BLOOD CREATINE PHOSPHOKINASE INCREASED 3690 0.1280
4 MYOSITIS 1124 0.1251
5 END STAGE RENAL DISEASE 2065 0.1131
6 HYPERLIPIDAEMIA 1325 0.1108
7 ARTERIOSCLEROSIS 989 0.1050
8 CORONARY ARTERY DISEASE 3180 0.1049
9 RENAL FAILURE ACUTE 4154 0.0978
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]